Outsourcing Drug Development

  • Outsourcing Drug Development
  • 2020 has been quite a year! Each year, we strive to provide you with a more innovative, simplified, and seamless early phase drug development journey. And the past 12 months have been no exception.

    Saving You Time With Tell Us Once™

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    An important consideration in choosing a research partner for your drug development programs is their experience and expertise in managing their study sites.

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Vaccine Development Realities (COVID-19 and Beyond)

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Partnership

    Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Trends in Early Phase Drug Development

    It’s the start of a new year, and our thoughts are turni

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    the study of Drug-Drug Interactions

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Does the CRO you’re working with have what it takes to successfully conduct First-in-Human (FIH) clinical research?

    Springtime brings the sunshine, warmer temperatures and if you’re into such things, a big basketball tournament. You are probably familiar with the March Madness tournament (which starts March 13th) and the bracket that goes along with it. It’s a single-elimination tournament that ends Thunderdome style (two teams enter, one team leaves victorious and all that).

    Subscribe to Outsourcing Drug Development